chemical cross-linking, together with mass spectrometry (Ms), is a powerful combination for probing subunit interactions within static protein assemblies. to probe conformational changes in response to stimuli, we have developed a comparative cross-linking strategy, using lysine-specific deuterated and nondeuterated bis(sulfosuccinimidyl)suberate cross-linking reagents (Bs3). Here we describe the experimental procedures as well as the data analysis, validation and interpretation. the protocol involves first assigning cross-linked peptides in the complex without ligand binding, or with post-translational modifications (ptMs) at natural abundance, using a standard procedure with labeled cross-linkers, proteolysis and assignment of cross-linked peptides after liquid chromatography-tandem Ms (lc-Ms/Ms) and database searching. an aliquot of the protein complex is then exposed to a stimulus: either ligand binding or incubation with a phosphatase or kinase to bring about changes in ptMs. two solutions-one containing the apo/untreated complex and the other containing the enzymatically modified/ligand-bound complex-are then cross-linked independently. typically, nondeuterated Bs3-d0 is used for the untreated complex and deuterated Bs3-d4 is used for the experiment. the two aliquots are then incubated at equal concentrations, digested and processed as before. the ratios of labeled and unlabeled cross-linked peptides provide a direct readout of the effect of the stimulus. We exemplify our method by quantifying changes in subunit interactions induced by dephosphorylation of an atp synthase. the protocol can also be used to determine the conformational changes in protein complexes induced by various stimuli including ligand/drug binding, oligomerization and other ptMs. application of the established protocol takes ~9 d, including protein complex purification.
IntroDuctIon
Proteins and their assemblies are the building blocks of the cell, and they form the basis of all cellular processes. To carry out their function, proteins often network with other proteins via transient associations. This aspect, coupled with individual protein dynamics when binding to ligands, cofactors or substrates, increases the complexity of protein assemblies. Because of this complexity, numerous structural techniques have evolved to study proteinprotein and protein-ligand interactions. One such technique, chemical cross-linking, has provided considerable insights into the structural arrangement within a number of protein networks and assemblies including PP2A (ref. 1) , TriC/CCT 2 and Pol II-TFIIF 3 . When chemical cross-linking is used in conjunction with nondenaturing (native) MS, for example in the structure elucidation of clustered regularly interspersed short palindromic repeats (CRISPRs), both subunit stoichiometry and interactions could be defined and, together with an electron microscopy density map, the first molecular model could be described 4 . These examples highlight the power of chemical cross-linking, particularly in an integrative modeling strategy, when used in combination with other approaches 5 .
The basis of chemical cross-linking involves covalent linkage of two reactive groups of amino acid side chains, in close proximity, using bifunctional chemical reagents 6, 7 . Typically, after crosslinking, proteins are hydrolyzed using specific endoproteinases, yielding a mixture of peptides and covalently linked di-peptides, which are then separated and analyzed by LC-MS/MS to yield sequence information. Although peptide and protein identification by database searching is relatively straightforward and underlies all current proteomics strategies 8 , data analysis of cross-linked di-peptides remains challenging. The number of possibilities for cross-linked di-peptides increases substantially, as different proteins or distal sequence regions can become covalently linked. This difficulty is partially alleviated by the introduction of stable isotope-labeled cross-linking reagents used in 1:1 ratios, giving rise to pairs of peaks of equal intensity in mass spectra, facilitating identification and database searching 9 . When used in this way, chemical cross-linking has provided insights into the subunit arrangement within large protein assemblies, with the length of the cross-linker defining a distance constraint that can be implemented in computational modeling 1, 3 . Typically, however, chemical cross-linking defines subunit interactions within one conformation of a protein assembly, or an average of dynamic states populated in solution 3, 10 . To define conformational changes in response to PTMs or ligand binding, new methods that report on changes in subunit interactions or spatial proximity of reactive amino acid residues are required.
How are conformational changes in protein complexes analyzed by other structural techniques?
Protein interactions, studied using conventional structural techniques, such as X-ray crystallography, provide atomic insight into static interactions within protein assemblies 11 . Electron microscopy, with the advent of new detectors, is now capable of near-atomic resolution 12 , and nuclear magnetic resonance spectroscopy is attractive as it is capable of reporting on an average of coexisting populations in solution 13 . However, challenges remain for these established structural biology approaches when studying large assemblies with high compositional and conformational heterogeneity.
MS, in combination with other techniques such as ion mobility or hydrogen/deuterium exchange has provided new insights into dynamic conformational changes within heterogeneous protein complexes [14] [15] [16] . These studies usually include comparison of two experiments: one studying the protein complex in its native state (i.e., in its wild-type, apo, untreated form) and a second experiment after the complex has undergone structural change (i.e., upon ligand binding or removal of PTMs). In this manner, chemical cross-linking has been applied to the study of the effects of ligand binding 17 and conformational changes associated with protein aggregation in solution 18 . By contrast, ion mobility MS is a gas phase-separation method that has given insight into the gross conformational changes that arise owing to lipid/drug and DNA/RNA binding [19] [20] [21] . However, ion mobility (IM)-MS methods lack the sensitivity needed to define precise changes in subunit interactions or subtle conformational changes in protein folds.
A more sensitive approach than IM-MS involves the application of either hydrogen/deuterium exchange or hydroxyl radical footprinting in conjunction with MS. When carried out in a timedependent way, the level of modification (i.e., incorporation of deuterium to the protein backbone or oxidation of amino acid side chains) after different time intervals can be used to report on conformational change as a function of time 16, 22 . Many spectra are acquired and interpreted to reveal conformational dynamics of protein complexes. Hydrogen/deuterium exchange or hydroxyl radical footprinting methods compare protein complexes in different states, often in independent experiments. This can be timeconsuming, and it requires reproducible instrument conditions (e.g., when different time points are analyzed over a course of several minutes or hours). In addition, only an indirect measurement of conformational change is provided. The extent of perturbation of subunit interfaces is therefore sometimes difficult to interpret directly from the data.
In this protocol, we describe a further development in the application of chemical cross-linking that overcomes some of the limitations to the independent experiments described above. In a procedure that we termed 'comparative chemical cross-linking,' we showed how we can probe conformational changes in protein complexes, specifically in the chloroplast ATPase 23 . We make use of stable isotope-labeled cross-linking reagents to cross-link protein complexes independently in different conformations and to process these complexes within the same solution. Practically, this is achieved by pooling equimolar aliquots of the two cross-linked protein complexes. Consequently, both complexes are digested and analyzed together, enabling us to directly compare different conformational states in one experiment. As our approach uses cross-linkers with different stable isotopes, it enables us to compare protein complexes and their responses to defined stimuli and to obtain quantitative values for protein interactions giving insights into the extent of conformational change.
How does comparative cross-linking work?
The first step in our protocol is to assign the cross-linked peptides in the complex without ligand binding or with natural abundance PTMs (Fig. 1, step i ). This is achieved by using a standard procedure with labeled cross-linkers, proteolysis and subsequent assignment of cross-linked peptides. This assignment then provides the starting point for investigating change. For comparative cross-linking, an aliquot of the protein complex is exposed to a stimulus, e.g., a ligand, or to incubation with a phosphatase or kinase to bring about changes in PTMs. Solutions containing either the apo/untreated complex or enzymatically modified/ ligand-bound complex are then cross-linked independently with BS3 (bis(sulfosuccinimidyl)suberate), typically nondeuterated BS3-d0 for the untreated complex and deuterated BS3-d4 for the experiment. After cross-linking, an aliquot of the BS3-d0 protein complex (control) is pooled with equal volumes of the BS3-d4 cross-linked complex in a 1:1 ratio (Fig. 1, step ii) and processed together throughout sample preparation and LC-MS/MS analysis. Both protein complexes are therefore separated simultaneously on a 1D gel; the resulting bands are subjected to tryptic digestion and the cross-linked peptides are identified by LC-MS/MS after database searching (Fig. 1, steps iii-v) .
Crucial to our method is the fact that the BS3 cross-linked peptides (d0/d4) derived from complexes, exposed to different conditions, have the same physicochemical properties in terms of elution time, ionization and fragmentation, but importantly they are separated by a defined mass shift according to the stable isotopes incorporated. This procedure therefore results in pairs of peaks, with relative intensities reflecting changes in subunit interactions in response to a stimulus, and thus it provides a direct and quantitative readout of these effects. By extracting ion chromatograms (so-called XICs) of d0-and d4-cross-linked peptides and comparing the ratios of the peak areas (d0:d4), we obtain quantitative values for changes in protein-protein interactions (Fig. 1, step vi) . Figure 2 gives an overview of the protocol and the timing details involved in each step. An alternative comparative cross-linking protocol includes in-solution digestion and reduction of sample complexity by additional chromatography steps after cross-linking and tryptic digestion. Different chromatographic steps, such as cation exchange, could also serve to verify subtle differences in cross-linked peptides. Reproducibility can also be assessed by performing comparative cross-linking in a reverse direction (i.e., by swapping the cross-linkers such that the labeled and unlabeled cross-linking reagents are used for complexes in the control and the experiment, respectively). A similar step is often included in quantitative proteomic experiments to confirm the changes observed (e.g., ref. 24) .
What is the advantage of comparative cross-linking?
One of the most exciting attributes of comparative cross-linking is its ability to deliver quantitative values for structural changes within protein assemblies. In contrast, methods that have been applied in previous studies (hydrogen exchange and radical footprinting) only provide insights into the structural change itself but not the extent of change. This will probably prove powerful when ranking ligands, for example, on the basis of their effects on subunit interactions. Moreover, we anticipate that these quantitative values will enable calculation of K d values for ligand binding to protein complexes.
An experimental advantage of comparative cross-linking over conventional techniques is that structural information is deduced from the same measurement, i.e., the protein complexes in different conformational states are analyzed at the same time. Pooling of the samples thus reduces the time needed for sample preparation or LC-MS/MS analysis. Importantly, similar to quantitative proteomics 25 , pooling of samples at an early time point minimizes errors caused during sample processing (e.g., sample loss, mixing errors and so on).
Another potential advantage of our protocol is that it is universal, enabling the use of different cross-linking reagents. All chemical cross-linkers in unlabeled and labeled form (e.g., incorporation of 2 D, 15 N or 13 C) can be used to perform comparative cross-linking experiments. Moreover, the scope could be broadened to include labeled photo-cross-linking reagents 26 . As different biological systems require very different cross-linking strategies (e.g., integral membrane proteins and nucleic acids), adaptability to a wide range of cross-linkers will be particularly powerful. A further consideration is the use of isotopically labeled cross-linkers to enable so-called multiplexing of experiments, i.e., more than two conformational states can be compared in one measurement with the use of multiple cross-linkers. The BS3 cross-linker used in this protocol, for example, is available in two deuterated forms (d4 and d8), thus allowing us to compare three different stimuli/experimental conditions of the same protein complex. 
Which changes can be probed by comparative cross-linking?
Conformational changes in protein complexes are induced by a variety of stimuli, including ligand binding, activation/ deactivation, oligomerization or changes in PTMs (Fig. 3) . As such we believe that our comparative cross-linking strategy is widely applicable not only for the phosphorylation events described below but also for other modifications, including methylation, acetylation and glycosylation, as well as for ligand binding (including lipid and drug binding) and oligomerization. Essentially, conformational changes that are caused by a defined stimulus can be probed. However, one prerequisite is that the stimulus can be controlled in vitro or in vivo, i.e., the two states of the protein complex need to be accessible in their isolated forms to allow cross-linking of the two states independently.
We have successfully applied our protocol to study conformational changes in a variety of biological systems. These included tRNA binding to eukaryotic initiation factor 2 from yeast (C.S. and C.V.R., unpublished data) and subcomplexes of the Hsp70-Hsp90 cycle (N. Morgner, C.S., I.O. Ebong, V. Beilsten-Edmands, N.A. Patel and E. Kirschke, unpublished data). Comparative crosslinking of subcomplexes of the Hsp70-Hsp90 cycle allowed us to study phosphorylation-dependent dimerization of Hsp70 and conformational changes in response to binding of different nucleotides such as ATP, ADP and nonhydrolyzable analogs.
We also envisage that oligomerization of proteins and formation of super-complexes from multi-subunit protein complexes represents a promising application. For multi-subunit complexes, this allows not only a measure of conformational change in protein subunits upon complexes formation but also changes in their interaction surfaces. In the latter case, cross-linking intensities at interaction interfaces can be drastically reduced after the formation of new protein complexes (Fig. 3) . These changes can be incorporated into integrative approaches and can provide crucial information for the assembly of molecular models.
What are the limitations of comparative cross-linking? As described above, comparative cross-linking is widely applicable and particularly powerful when dynamic heterogeneous protein complexes are studied. However, one major drawback is its time-consuming data analysis workflow (Fig. 4) . There are several software packages for the identification of cross-linked di-peptides available [27] [28] [29] [30] ; however, none of these packages include quantification of the cross-linked peptides. Manual quantification, in addition to manual inspection of MS and MS/MS spectra, is therefore required for use in this protocol. Integrating quantification tools for peak intensities into software packages thus represents a future improvement for automation of this protocol. An initial proof-of-principle study reported the quantification of differentially cross-linked di-peptides by integrating the quantification approach into cross-linking identification tools 31 .
A second potential drawback to the application of comparative cross-linking is the limitation imposed by conformational changes that are beyond the range of chemical cross-linker, i.e., the distances between cross-linked amino acid residues can no longer be bridged by the cross-linking reagent. Minimal changes in the distance between two residues, i.e., within the range used by the cross-linking reagent, cannot be detected because the respective amino acid residues can form cross-links in both conformational states. With the emergence of an increasing array of synthetic cross-linking reagents, fine-tuning the length of a cross-linker for a particular investigation may become a real possibility in the very near future 32 . 
MaterIals

REAGENTS
EQUIPMENT SETUP LC-MS system
As different laboratories have their own individual setups for LC-MS/MS, we have not provided a specific procedure for this step. General guidelines for the analysis of samples generated for proteomic studies should be followed. Note, however, the following recommendations for LC-MS analysis specifically for cross-linked peptides: Cross-linked di-peptides have a higher hydrophobicity than linear peptides, and the gradient during LC should be adjusted. We therefore use a gradient from 4-80% ACN and acquire MS and MS/MS spectra during the full gradient. In addition, as cross-linked di-peptides are usually of lower intensity compared with non-cross-linked peptides, we use long HPLC columns to achieve the highest separation of the peptide mixture and thus ensure high analytical depth during the analysis. Typically, we use 50-cm columns packed with C18 material.
The mass spectrometer should be operated in a data-dependent mode. We use in our analyses an LTQ-Orbitrap XL mass spectrometer. Full-scan MS spectra are acquired in the Orbitrap (resolution of 30,000 at m/z 400 and an automatic gain control target at 10 6 ) and MS/MS spectra are acquired in the linear ion trap. Precursors of unknown charge state, as well as singly charged ions, are excluded from the analysis and selected precursors are dynamically excluded for 30 s. Depending on the mass spectrometer available, these settings might need to be adjusted. Please also note that some current mass spectrometers also allow the analysis of fragment ions in the orbitrap using different fragmentation methods such as higher collision dissociation. The recording of these highresolution fragment spectra can be used to confirm the identity of the crosslinked peptide. proceDure complex purification • tIMInG 1-5 d 1| Prepare and purify the protein or protein complex that you wish to study. Proteins and protein complexes obtained from various purification protocols can be analyzed by cross-linking and comparative cross-linking. Use amine-free buffer systems such as phosphate buffers or HEPES during the purification and isolation procedures. A protein complex concentration that yields well-stained Coomassie blue bands on a protein gel is suggested for successful application. Protein contamination of the complex does not influence the results of our protocol as long as the protein complex of interest is highly abundant in the sample and the contaminating proteins do not interact with the protein of interest or influence its activity (or conformational change).  crItIcal step Handling of the protein complex (e.g., thawing/freezing, storage conditions) is specific to the system under investigation and the usual techniques should be followed; in some cases, it will be possible to store the protein complex, whereas in others it might be necessary to assemble the complex immediately before performing the experiment.  crItIcal step Buffer systems and additives that contain primary amines quench the cross-linking reagent and thus lower the cross-linking yield. They should therefore be avoided during protein complex purification or be exchanged against compatible buffers before cross-linking the protein complex. Low protein concentrations of the complex under investigation will also affect the cross-linking yield.
chemical cross-linking • tIMInG 90 min-2 h 2|
The first step toward comparative cross-linking involves cross-linking of the protein complex in its untreated (i.e., apo and natural) state (option A, followed by sample preparation and MS as described in Steps 3-14) ; the results of this experiment form the basis of the cross-linking experiment. The amount of cross-linking reagent needs to be optimized with respect to the protein concentration. Once this has been done, perform the comparative cross-linking experiment using deuterated and nondeuterated cross-linking reagents to find out what conformational changes in the protein complex result from induction by a defined stimulus (option B, followed by .  crItIcal step Cross-linked protein bands of higher molecular weight should have comparable intensity to un-cross-linked proteins. A gel with comparable intensities is shown in Figure 5 for a 20-µl aliquot of the cATPase (~10 µM).  crItIcal step Avoid reaction buffers and additives that contain amine groups, as these might be reactive with the cross-linking reagents and thus induce quenching. (iv) Perform Step 2A(i-iii) under the optimal reaction conditions, and proceed immediately with Step 3A or 3B.
Before performing comparative cross-linking ( Step 2B), analyze the results. Identified cross-links yield information on protein interactions in the apo (untreated) form of the protein complex. (B) comparative cross-linking to probe conformational changes (i) Induce desired stimulus to the purified protein complex and incubate for the required time. Prepare a control sample (no addition of the stimulus-inducing enzyme, ligand and so on) and incubate it for the same time. We incubated the cATPase with a phosphatase and incubated a control sample without phosphatase for the same time (Figs. 6 and 7) .
(ii) Add BS3-d4 solution to the stimulated protein complex and BS3-d0 solution to the control sample (untreated/ apo form). Mix it gently by pipetting the solution several times.  crItIcal step It is advised to repeat the comparative cross-linking experiment and reverse the use of deuterated and nondeuterated cross-linker. Use optimized concentrations of the cross-linking solution obtained from
Step 2A(i-iii).  crItIcal step It is important to pool the two samples in exactly the same amounts. Use the same protein concentrations and buffer volumes for incubation of the two samples, or adjust the volume accordingly. Pool samples in a fresh sample tube to minimize mixing errors.
sample preparation for lc-Ms/Ms analysis • tIMInG 2-3 d (including overnight incubations) 3|
Cross-linked peptides are usually of lower abundance than linear peptides that have not been cross-linked. To reduce the background of linear peptides and enhance analytical depth, and thus to increase the chances of identifying cross-linked peptides during LC-MS/MS analysis, either separate the proteins by gel electrophoresis and perform in-gel digestion 33 (option A) or perform in-solution digestion and separate the peptides using cation exchange chromatography (option B). Both options require similar quantities of protein complex and deliver comparable results. Different laboratories, however, prefer in-gel or in-solution digestion protocols and both have their advantages and disadvantages. In-gel digestion, lc-Ms/Ms analysis • tIMInG 90 min-2 h 4| Dissolve the dried peptide samples by adding loading buffer and sonicating for 1-2 min. We recommend dissolving the samples obtained from one gel band or one elution step after SCX in 20 µl of loading buffer and injecting 5 µl of the solution into the nanoLC. Depending on the sensitivity of the mass spectrometer used, the volume of injection may differ and need to be adjusted to obtain a good signal by LC-MS/MS.
5| Analyze the samples by nanoLC-MS/MS (see Equipment Setup).
Identification of cross-linked peptides • tIMInG 1-3 h per sample  crItIcal There are various software packages for the analysis of cross-linked peptides available [27] [28] [29] [30] . In our studies, we used the freely available search engine MassMatrix 29 (http://www.massmatrix.net). However, other software for the identification of cross-linked peptides is compatible with our protocol. We describe below our data analysis workflow (Fig. 4) using the MassMatrix webserver.
6|
Convert the raw data to .mzXML or .mgf format using the MassMatrix file conversion tool. For further information, see http://www.massmatrix.net.
7|
Generate a protein database for cross-linking experiments in .fasta format, as described in the MassMatrix user manual (http://www.massmatrix.net).
8|
Define the mass of the deuterated cross-linker (BS3-d4) in the MassMatrix settings (see http://www.massmatrix.net for help). Nondeuterated (d0) BS3 is included in the default settings.
9| Submit database search on the webserver or computer version of the MassMatrix search engine using BS3-d0 as the cross-linker (Fig. 4, step  crItIcal step The parameters might affect the database search result. It might be necessary to adjust the precursor and product ion tolerances depending on the mass accuracy achieved during LC-MS analysis. The minimum scores listed here present stringent values. If necessary, they can be lowered to obtain a higher number of potential cross-linked peptides after database searching.
10|
Scan the database search output for potential cross-linked peptides.
? trouBlesHootInG 11| Check manually the respective MS spectra for the presence of specific peak pairs indicative for the d0/d4-BS3 cross-linker (Fig. 4, step iii) . Spectra without specific peak pairs represent false-positive hits (Fig. 4, step iv) .  crItIcal step Check the MS spectra carefully. Peptides representing a specific peak pair have the same charge state and an exact mass difference of 4 Da (when using BS3-d0/d4). When performing the database search using BS3-d0, the heavy cross-linked di-peptide should be present in the respective MS spectrum and vice versa. ? trouBlesHootInG 12| Check the quality of MS/MS spectra of confirmed potential cross-links (Fig. 4, step v) . Reject the spectra of low quality that do not allow identification of the cross-linked peptides (Fig. 4, step vi) . Add these to the list of false positives.
13|
Repeat the database search, this time using BS3-d4 as the cross-linker, and analyze the database output as described in Steps 10-12.
14| Calculate the false discovery rate (FDR) using the following equation: FDR (%) = FP/PXLs × 100, where FP is the number of false positives (see above) and PXLs is the number of potential cross-links obtained after database search (Fig. 4, step vii) .
Quantification of identified cross-links
• tIMInG 1-3 h per sample  crItIcal Quantification of cross-links is performed to distinguish protein-protein interactions that change upon stimulation of the protein complex from interactions that do not change. This quantification is based on intensities of the respective cross-linked peptides, which are obtained from XICs. There are different software packages available that can be used to generate XICs. The software of choice needs to support raw data files of the mass spectrometer used. It is therefore recommended to use the instrument control software provided with the mass spectrometer (e.g., XCalibur, Thermo Scientific).
15|
Generate XICs of the validated d0-and d4-cross-linked peptides (Fig. 4, step viii) . Follow the instruction manual of the manufacturer. We used XCalibur (Thermo Scientific) to generate XICs of the cross-linked peptides.
16| Calculate d0/d4 and d4/d0 ratios by dividing peak areas of respective XICs (i.e., XICs of peak pairs) (Fig. 4, step ix) . ? trouBlesHootInG 17| Inspect obtained d0/d4 and d4/d0 ratios. Cross-links that are not affected by the induced stimulus (e.g., ligand binding or incubation with an enzyme) should show a ratio close to 1. Cross-links that are affected show ratios that differ from 1 (Fig. 4, step x) .  crItIcal step Cross-linking ratios of interactions that do not change usually scatter around 1. Depending on the conformational change, these should be the majority of ratios obtained. In particular, intra-peptide cross-links should show a ratio of 1, as these are in general not expected to be affected by conformational change. If the majority of protein ratios scatter around a different value, normalization is needed (Fig. 4, step xi) . This is performed by calculating a normalization factor from the average ratio (normalization factor = 1/average protein ratio) and multiplying all ratios with this normalization factor. Normalization is correcting for mixing errors that have occurred during pooling of the samples (see above).
• tIMInG
Step 1, complex preparation and purification: 1-5 d (depending on the protein complex to be purified)
Step 
antIcIpateD results
We exemplify our comparative cross-linking strategy using the ATP synthase isolated from spinach chloroplasts (cATPase). First, we used a 1:1 mixture of d0:d4 BS3 to identify protein-protein interactions in the cATPase under natural conditions, i.e., before treatment with a phosphatase. We identified 105 intra-and inter-protein cross-links with an FDR of 9.29% and used this assignment as a basis for our comparative cross-linking strategy. We then took two aliquots of the complex, added a phosphatase to one and an equal volume of buffer to the other, and incubated the two solutions side by side (Fig. 6a) . After incubation, BS3-d4 was added to the phosphatase-treated aliquot, whereas BS3-d0 was added to the untreated cATPase. A 1:1 ratio of the two solutions (by volume) was then prepared and subjected to 1D gel separation, trypsin digestion and LC-MS/MS analysis. Ratios of the intensities of the labeled and unlabeled cross-linked peptides were obtained by generating XICs (Fig. 6b,c) . We found that although some labeled and unlabeled cross-linked peptides had similar intensities (Fig. 6b) , allowing us to define interactions not affected by dephosphorylation, the majority showed reduced intensities for labeled cross-linked peptides compared with unlabeled ones (Fig. 6c) . This reduction in intensity is consistent with a reduction in subunit interactions after dephosphorylation 23 (Fig. 7) . Because our method delivers quantitative values, we can compare changes in cross-links. For example, after dephosphorylation, cross-links between subunits I/II:α and α:β are 2-5-fold and 5-10-fold less intense, respectively. Therefore, we concluded that dephosphorylation has a greater effect on the α:β interface than on interactions between F 1 and the peripheral stalks. Together with results from mass spectra of intact complexes, our comparative cross-linking data prompt a mechanism whereby dephosphorylation causes conformational changes in the head, which increases access to nucleotidebinding sites 23 (Fig. 7) . autHor contrIButIons C.S. and C.V.R. designed the research; C.S. performed the experiments and analyzed the data; and C.S. and C.V.R. wrote the manuscript.
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